Psychedelics Today20 Loka 2023

PT453 – Katrin Preller, Ph.D. & Dr. Michael Mithoefer – Neuroplasticity, Individualized Integration, and Psychedelic Medicine – Israel 2024

In this episode, David interviews psychiatrist, main researcher behind the first US Phase II trial of MDMA-assisted psychotherapy, and Senior Medical Director at MAPS Public Benefit Corporation: Dr. Michael Mithoefer; and Research Group Lead at the University of Zurich, and Principal Clinical Biomarker Lead at Boehringer Ingelheim, Katrin Preller, Ph.D.

Mithoefer, Preller (and David) are speakers at the upcoming Psychedelic Medicine – Israel, which will now take place July 28 - 31, 2024, in Tel Aviv. They discuss the conference and their current research: Preller's neuroimaging and work with psilocybin for alcohol use disorder, and Mithoefer (likely) being extremely close to seeing the FDA approve MDMA-assisted psychotherapy. He talks about how the therapeutic protocols for MDMA-assisted psychotherapy were created, what it's like to be so close to legalization, and how the next challenges will be accessibility and not minimizing therapy in favor of faster turnover.

They discuss neuroplasticity and whether or not it actually translates into something in humans; the concept of performing brain scans before a psychedelic experience to look for trauma biomarkers (and how this could actually result in savings over time); the excitement of seeing clinical work and neuroscience progressing in parallel; why integration frameworks need to be individualized; and the importance of embracing different therapeutic approaches.

Click here to head to the show notes page.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(774)

PT 608 - PS 25 Morning Show - Day Two

20 Kesä 202551min

PS 25 - Morning Show Number 1

Joe Moore and Anne Philippi are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!

19 Kesä 202547min

PT 606 - Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences

n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of ...

16 Kesä 20251h 7min

PT 605 - Jeff Breau - Exploring Psychedelic Churches at Harvard Divinity School

In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and re...

27 Touko 20251h 39min

PT 604 - Paul Gillis-Smith - Psychedelics, Religion & Lisa Bieberman

In this episode, Joe Moore sits down with Paul Gillis-Smith from The Center for the Study of World Religions to discuss a range of fascinating topics. They begin by discussing the Harvard Divinity Sch...

21 Touko 20251h 30min

PT 603 - Dr Simon Ruffell - Other Ways of Knowing

In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. ...

13 Touko 20251h 6min

PT 602 - Iboga - Talia Eisenberg, Tom Feal, Dr. Lola "Dr. O" Hoba, Kevin Franciotti

Aspen Psychedelic Symposium 2024 – Hosted by Kevin Franciotti This powerful panel explores the healing potential and complex responsibilities that come with working with Ibogaine, a potent plant-based...

6 Touko 20251h 3min

PT 601 - Neuropharmacology: Psychedelics on the Brain - Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.

A panel discussion with Jim Harris, Rachel Zoeller, DPT, David W. McMillan, Ph.D., and Manesh Girn, Ph.D. Recorded live at the Aspen Psychedelic Symposium In this riveting and deeply personal conver...

2 Touko 202558min